Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
D-10 Therapeutics Logo
D-10 Therapeutics CB Rank
449652
Heat Score
75
D-10 Therapeutics is a biotechnology startup company that creates monoclonal antibodies for the treatment of sickle cell disease.
Founded
obfuscation
Private Torrance, California, United States1-10 www.d10therapeutics.com
Biopharma
Biotechnology
Therapeutics
Overview

D-10 Therapeutics
Heat Score
75

Growth Score
pts
in past quarter
Heat Score 75
-14 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About D-10 Therapeutics

CB Rank
449652
D-10 Therapeutics is a biotechnology startup company that creates monoclonal antibodies for the treatment of sickle cell disease.
Founded
obfuscation
Private Torrance, California, United States1-10 www.d10therapeutics.com
Biopharma
Biotechnology
Therapeutics

Key People

Details

Legal Name D-10 Therapeutics, Inc.
Operating Status Active
Company Type For Profit
Founders  Louis Jefferson, Metasebya Solomon
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Monoclonal Antibody Therapy for Sickle Cell Disease
A monoclonal antibody treatment designed to prevent sickle cells from adhering to blood vessel walls, reducing vascular occlusion and inducing vasodilation to improve blood flow.

Research & Development

D-10 Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Contacts 1

Employee Profiles

News

News and Press

News•Dec 23, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$74.5KThis year, D-10 Therapeutics is projected to spend $74.5K on IT, according to Aberdeen.

Active Website Tech Count

2D-10 Therapeutics is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 100m.
Sub-Organizations
Frequently Asked Questions

Where is D-10 Therapeutics's headquarters? D-10 Therapeutics is located in Torrance, California, United States.Who are D-10 Therapeutics's competitors? Alternatives and possible competitors to D-10 Therapeutics may include Pfizer, Moderna, and  Novartis.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|